1620085-02-0

Basic information

• Product Name: (R)-tert-butyl 3-(1-(4’-(2-(2-methylpyrrolidin-1-yl)ethyl)biphenyl-4-yl)cyclopentanecarboxamido)propanoate
• Synonyms: (R)-tert-butyl 3-(1-(4’-(2-(2-methylpyrrolidin-1-yl)ethyl)biphenyl-4-yl)cyclopentanecarboxamido)propanoate
• CAS NO: 1620085-02-0
• Molecular Weight: 504.713
• Mol File: 1620085-02-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (R)-tert-butyl 3-(1-(4’-(2-(2-methylpyrrolidin-1-yl)ethyl)biphenyl-4-yl)cyclopentanecarboxamido)propanoate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-tert-butyl 3-(1-(4’-(2-(2-methylpyrrolidin-1-yl)ethyl)biphenyl-4-yl)cyclopentanecarboxamido)propanoate(1620085-02-0)
• EPA Substance Registry System: (R)-tert-butyl 3-(1-(4’-(2-(2-methylpyrrolidin-1-yl)ethyl)biphenyl-4-yl)cyclopentanecarboxamido)propanoate(1620085-02-0)

Safety Data

• Hazardous Substances Data: 1620085-02-0(Hazardous Substances Data)

Upstream product

• 80789-69-1 1-(4-chlorophenyl)cyclopentane-1-carboxylic acid 
• 58620-93-2 β-alanine tert-butyl ester hydrochloride 
• 1620084-99-2 (R)-1-(4’-(2-(2-methylpyrrolidin-1-yl)ethyl)biphenyl-4-yl)cyclopentanecarboxylic acid 

Relevant articles and documents

BIPHENYL-ETHYL-PYRROLIDINE DERIVATIVES AS HISTAMINE H3 RECEPTOR MODULATORS FOR THE TREATMENT OF COGNITIVE DISORDERS

The present invention relates to compounds of Formula (Ia) and pharmaceutically acceptable salts, solvates, and hydrates thereof, that modulate the activity of the histamine H3 receptor (Ia). Compounds of the present invention and pharmaceutical compositions thereof are directed to methods useful in the treatment of histamine H3-associated disorders.